Spain
KeyZell, founded in 2020, is a promising Spanish startup spearheading innovation in the intersection of biotechnology and artificial intelligence. The company's slogan, "We developed for the first time an innovative and effective AI system for precision medicine oncology," encapsulates its ambitious approach to revolutionizing cancer treatment.
The core of KeyZell's innovation lies in its AI-driven tools. The AI Diagnosis leverages rapid X-ray tests, expanding its usability with advanced imaging methods like PET and DICOM standards. Meanwhile, its Oncology Precision System is noteworthy as the first validated precision medicine tool, aiding oncologists in selecting optimal treatments tailored to individual patient profiles.
With operations extending to Mexico, Australia, and Thailand, KeyZell is not only advancing AI in oncology but also progressing in the development of new anticancer drugs targeting tumor and metastasis challenges. Currently, there is no record of the latest investments or investors.
